Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Cubist

- PMLiVE

FDA backs Cubist’s antibiotic Zerbaxa

Combination cephalosporin and beta lactamase inhibitor wins US approval

The impending threat of antibiotic resistance

Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

- PMLiVE

NICE backs three ulcerative colitis treatments

Remicade, Simponi and Humira recommended for NHS reimbursement

- PMLiVE

Merck stumps up $375m for cancer firm OncoEthix

Follows $8.4bn deal to buy Cubist

Can Cinderella save us?

Antibiotic resistance to lead to millions of deaths

UK publishes first progress report for antimicrobial resistance strategy

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

Can Cinderella save us?

NICE wants responsible use of antibiotics in pneumonia

Drugs often prescribed to wrong patients

EU flag

Orphan drugs in latest CHMP recommendations

EMA advisers back new products from Genzyme, Boehringer and others

- PMLiVE

MSD launches diabetes programme with pharmacy network

Will support medicines optimisation in people prescribed Januvia

- PMLiVE

Antibiotics: pharma’s Cinderella story

There is hope that companies can safeguard against a new age of medicine

EU flag

EU consortium focuses on antibiotic ‘husbandry’

IMI-backed group to research ways to tackle antimicrobial resistance

- PMLiVE

Charity forms to tackle resistance to antibiotics

Antibiotic Research UK hopes to develop new drug in dive years

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links